Theravance Biopharma Inc (TBPH)
9.61
-0.36
(-3.61%)
USD |
NASDAQ |
Nov 21, 16:00
9.62
+0.01
(+0.10%)
After-Hours: 20:00
Theravance Biopharma Price to Book Value: 2.545 for Nov. 21, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| November 21, 2024 | 2.545 |
| November 20, 2024 | 2.641 |
| November 19, 2024 | 2.628 |
| November 18, 2024 | 2.514 |
| November 15, 2024 | 2.522 |
| November 14, 2024 | 2.535 |
| November 13, 2024 | 2.564 |
| November 12, 2024 | 2.36 |
| November 11, 2024 | 2.405 |
| November 08, 2024 | 2.368 |
| November 07, 2024 | 2.318 |
| November 06, 2024 | 2.307 |
| November 05, 2024 | 2.190 |
| November 04, 2024 | 2.175 |
| November 01, 2024 | 2.193 |
| October 31, 2024 | 2.182 |
| October 30, 2024 | 2.243 |
| October 29, 2024 | 2.291 |
| October 28, 2024 | 2.323 |
| October 25, 2024 | 2.265 |
| October 24, 2024 | 2.288 |
| October 23, 2024 | 2.286 |
| October 22, 2024 | 2.331 |
| October 21, 2024 | 2.294 |
| October 18, 2024 | 2.331 |
| Date | Value |
|---|---|
| October 17, 2024 | 2.283 |
| October 16, 2024 | 2.304 |
| October 15, 2024 | 2.278 |
| October 14, 2024 | 2.180 |
| October 11, 2024 | 2.201 |
| October 10, 2024 | 2.135 |
| October 09, 2024 | 2.135 |
| October 08, 2024 | 2.100 |
| October 07, 2024 | 2.132 |
| October 04, 2024 | 2.145 |
| October 03, 2024 | 2.145 |
| October 02, 2024 | 2.175 |
| October 01, 2024 | 2.175 |
| September 30, 2024 | 2.135 |
| September 27, 2024 | 2.046 |
| September 26, 2024 | 2.036 |
| September 25, 2024 | 2.010 |
| September 24, 2024 | 2.026 |
| September 23, 2024 | 2.006 |
| September 20, 2024 | 2.023 |
| September 19, 2024 | 2.074 |
| September 18, 2024 | 2.089 |
| September 17, 2024 | 2.081 |
| September 16, 2024 | 2.051 |
| September 13, 2024 | 2.056 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.353
Minimum
Nov 02 2022
2.641
Maximum
Nov 20 2024
1.914
Average
1.937
Median
Feb 09 2024
Price to Book Value Benchmarks
| Corcept Therapeutics Inc | 9.171 |
| Madrigal Pharmaceuticals Inc | 9.240 |
| Ionis Pharmaceuticals Inc | 8.090 |
| Jazz Pharmaceuticals PLC | 1.813 |
| NovaBay Pharmaceuticals Inc | 3.299 |
Price to Book Value Related Metrics
| PS Ratio | 7.430 |
| PEG Ratio | -1.506 |
| Price | 9.61 |
| Earnings Yield | -10.51% |
| Market Cap | 472.56M |
| PEGY Ratio | -1.506 |